Quality of life after coronary revascularization in the United States and Canada

M G Bourassa1, M M Brooks, D B Mark

  • 1Montreal Heart Institute, Quebec, Canada.

Insights

Canadian patients experienced greater initial quality of life improvements after coronary revascularization compared to US patients, despite similar cardiac event rates. However, Canadian patients reported more angina symptoms long-term, suggesting different treatment thresholds.

Area of Science:

  • Cardiology
  • Health Services Research
  • Comparative Effectiveness

Background:

  • Cardiac procedures are less frequent in Canada than the US, despite similar cardiac death and myocardial infarction rates.
  • Initial coronary revascularization patient outcomes require comparative analysis between Canadian and US healthcare systems.

Purpose of the Study:

  • To compare long-term symptoms and quality of life in Canadian and American patients following initial coronary revascularization.
  • To investigate differences in functional status, angina prevalence, and repeat revascularization rates between the two countries.

Main Methods:

  • A comparative analysis of 161 Canadian patients (Montreal Heart Institute) and 934 US patients from the Bypass Angioplasty Revascularization Investigation.
  • Patients were randomized to percutaneous transluminal coronary angioplasty or coronary artery bypass graft surgery, with outcomes tracked for 5 years.
  • Functional status assessed via Duke Activity Status Index; angina prevalence and repeat procedures were documented.

Main Results:

  • Canadian patients showed greater 1-year functional status improvement (Duke Activity Status Index +13.5 vs. +6.0), though this difference diminished over 5 years.
  • Angina prevalence was similar at 1 year but significantly higher in Canadian patients at 5 years (36% vs. 16%).
  • Repeat revascularization was less frequent in Canada over 5 years (26% vs. 34%), particularly CABG after PTCA (18% vs. 32%).

Conclusions:

  • Canadian patients may require more severe anginal symptoms before undergoing coronary revascularization.
  • Despite this, Canadian patients achieve greater quality of life improvements post-procedure.
  • Differences in healthcare access or practice patterns may influence long-term outcomes and symptom burden.

Related Concept Videos

Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
Acute Coronary Syndrome V: Nursing Management01:26

Acute Coronary Syndrome V: Nursing Management

Nursing Assessment:Nursing management of acute coronary syndrome (ACS) involves taking the patient's history, focusing on primary complaints such as chest pain, dyspnea, and excessive sweating (diaphoresis), as well as other symptoms like back or jaw pain, nausea, vomiting, palpitations, dizziness, and fatigue. The nurse also reviews the patient's history of cardiac events, risk factors such as hypertension, diabetes, smoking, family history, and current medications.In the objective assessment,...